What Is the Difference Between IBS and Colitis?

IBS (irritable bowel syndrome) is a functional disorder, meaning your gut doesn’t work the way it should but isn’t physically damaged. Colitis, most commonly ulcerative colitis, is an inflammatory disease that causes visible damage to the lining of your colon. That single distinction, inflammation versus no inflammation, is the most important difference between the two conditions and drives nearly every other difference in symptoms, diagnosis, treatment, and long-term risk.

Both can cause abdominal pain, diarrhea, and bloating, which is exactly why they’re so often confused. But what’s happening inside the body is fundamentally different, and the consequences are too.

What’s Actually Happening in Your Gut

IBS is a problem of communication between your brain and your digestive tract. The nerves and muscles that move food through your intestines misfire, causing pain, cramping, and unpredictable bowel habits. If a doctor were to look at your colon during a colonoscopy, it would appear normal. There’s no ulceration, no swelling, no bleeding tissue. The gut looks healthy even though it doesn’t feel that way.

Ulcerative colitis is the opposite. It’s a chronic autoimmune condition in which your immune system attacks the lining of the colon, creating real, visible inflammation. During a colonoscopy, a doctor can see continuous inflammation spreading upward from the rectum: the tissue looks grainy, bleeds easily, may have deep ulcers, and loses the normal blood vessel pattern you’d see in a healthy colon. Biopsies show immune cells infiltrating the tissue and distorted structures in the intestinal lining. In up to 25% of people with extensive ulcerative colitis, mild inflammation even extends into the last portion of the small intestine.

Symptoms That Overlap and Symptoms That Don’t

The overlap is real. Both conditions cause abdominal pain, bloating, diarrhea, constipation (more common in IBS), and urgency. Both are also linked to higher rates of anxiety and depression. This overlap is partly why many people spend months or years uncertain about their diagnosis.

But several symptoms point strongly toward colitis rather than IBS:

  • Blood in your stool. This is a hallmark of ulcerative colitis. IBS does not cause bleeding.
  • Unexplained weight loss. Chronic inflammation interferes with nutrient absorption and increases your body’s energy demands.
  • Fever. Active colitis can cause low-grade fevers, especially during flares. IBS does not.
  • Anemia. Ongoing blood loss and inflammation deplete iron and red blood cells. People with ulcerative colitis often have lower hemoglobin levels (around 11 g/dL on average in one study, compared to about 13.4 g/dL in IBS patients).
  • Nighttime diarrhea. Waking up at night with urgent diarrhea suggests an inflammatory process. IBS symptoms tend to ease during sleep.

For IBS, abdominal pain is the defining feature. Without it, a diagnosis of IBS isn’t considered valid under current diagnostic guidelines. The pain is typically tied to bowel movements: it gets worse before one and often improves after. The pattern also matters. Symptoms need to have been present for at least six months, with active symptoms occurring over the most recent three months, before IBS is formally diagnosed.

How Each Condition Is Diagnosed

IBS is largely a diagnosis of exclusion. There’s no blood test, biopsy, or imaging study that confirms it. Doctors diagnose IBS based on your symptom pattern (recurrent abdominal pain linked to changes in bowel habits) after ruling out other conditions. If your symptoms fit and no red flags are present, further testing may not be necessary.

Ulcerative colitis requires objective evidence. A colonoscopy is the primary tool, and what the doctor sees is distinctive: continuous inflammation starting at the rectum and extending upward without gaps of healthy tissue in between. Biopsies confirm the diagnosis by showing specific patterns of immune cell activity, including immune cells burrowing into the glands of the intestinal lining and structural changes that indicate chronic, ongoing damage.

One test that helps sort the two conditions apart before a colonoscopy is a stool test for calprotectin, a protein released by immune cells during inflammation. In one comparative study, people with ulcerative colitis had average calprotectin levels around 594 micrograms per gram, while people with IBS averaged about 29. That’s a roughly 20-fold difference. A high calprotectin result strongly suggests inflammation is present and typically leads to a colonoscopy. A low result makes colitis much less likely.

Where Microscopic Colitis Fits In

There’s a third condition worth knowing about: microscopic colitis. It causes chronic, watery diarrhea and looks completely normal during a colonoscopy. The inflammation only shows up under a microscope when tissue samples are examined, which is how it gets its name. Between 14% and 56% of people with microscopic colitis meet the symptom criteria for IBS, making it easy to misdiagnose. If you’ve been told you have IBS but your primary symptom is persistent watery diarrhea without much pain, microscopic colitis is worth investigating with biopsies taken during a colonoscopy.

Treatment Differences

The treatment strategies reflect the underlying problem. IBS management focuses on calming the gut-brain connection and managing symptoms. This typically involves dietary changes (many people respond well to reducing certain fermentable carbohydrates), stress management, and medications that target specific symptoms like cramping, diarrhea, or constipation. Because IBS doesn’t cause structural damage, the goal is symptom relief and quality of life.

Ulcerative colitis treatment aims to control inflammation and prevent it from damaging the colon further. People with mild to moderate disease often start with anti-inflammatory medications taken by mouth or as rectal formulations. When inflammation is more severe or widespread, treatments that suppress the overactive immune response become necessary. Some of these are given by injection or infusion at regular intervals. During flares, short courses of steroids may be used to bring inflammation under control quickly. In the most severe cases, or when medications stop working, surgical removal of the colon is an option, and it’s effectively a cure since there’s no colon left to inflame.

Colitis also requires ongoing monitoring. Even when you feel well, your doctor will periodically check for active inflammation through stool tests, blood work, or colonoscopy, because silent inflammation can still be causing damage.

Long-Term Risks

This is where the distinction between the two conditions matters most. IBS does not raise your risk of colorectal cancer, regardless of how long you’ve had it. It doesn’t damage your intestines, doesn’t progress to a more serious disease, and doesn’t shorten your life expectancy. It can significantly affect quality of life, but it isn’t dangerous.

Ulcerative colitis carries a meaningfully higher risk of colorectal cancer. The prolonged inflammation in the colon promotes cellular changes over time that can become cancerous. This risk increases with the duration and extent of the disease, which is why people with ulcerative colitis are placed on surveillance colonoscopy schedules, typically starting eight to ten years after diagnosis, with repeat exams every one to three years depending on their individual risk factors.

Can You Have Both?

Yes. IBS-like symptoms are common in people with ulcerative colitis, even when their inflammation is well controlled. Research shows a gradient of immune cell activity in the colon that runs from healthy tissue at the low end, through IBS, through microscopic colitis, to ulcerative colitis in remission, and finally to active ulcerative colitis at the high end. The two conditions aren’t as neatly separated as textbooks once suggested. If you have colitis and still experience pain, bloating, or erratic bowel habits despite your inflammation being in remission, a functional component like IBS may be contributing. Sorting out which symptoms come from residual inflammation and which come from gut-brain dysfunction is one of the trickier problems in gastroenterology, but it changes how your symptoms are treated.